Sharpe ratio is not yet available for ACLX. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar stocks
The table compares Arcellx Inc's Sharpe Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how ACLX's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 5, 2026.
| Symbol | Name | 1Y Sharpe Ratio | 5Y Sharpe Ratio | 10Y Sharpe Ratio | All Time Sharpe Ratio |
|---|---|---|---|---|---|
| RVMDW | Revolution Medicines Inc. Warrant | 14.24 | |||
| SLGL | Sol-Gel Technologies Ltd. | 9.11 | |||
| CLYM | Climb Bio Inc | 7.55 | |||
| ERAS | Erasca, Inc. | 7.50 | |||
| TNGX | Tango Therapeutics, Inc. | 6.69 | |||
| NBTX | Nanobiotix S.A. | 6.56 | |||
| DRTSW | Alpha Tau Medical Ltd. Warrant | 6.34 | |||
| OVID | Ovid Therapeutics Inc. | 6.24 | |||
| RLMD | Relmada Therapeutics, Inc. | 6.20 | |||
| ORKA | Oruka Therapeutics, Inc | 5.80 | |||
| ACLX | Arcellx Inc | — |
Loading charts...
Sharpe Ratio Calculator
How does ACLX fit in your portfolio?
Add your other holdings to see your portfolio's Sharpe Ratio and find out.
Analyze Your Portfolio